Sector: Pharmaceuticals & Biotechnology

Mid Cap

Cohance Lifesciences Share Price

COHANCE

₹441

10.20(2.37%)

9th Jul 2026 | 3:28 PM

NSE : COHANCE

Open Free Demat Account

Cohance Lifesciences Performance

Price Movement

₹441.00

₹425.10

₹448.00

↘ Today's Low↗ Today's High

1 Year Performance

₹441.00

₹266.70

₹1121.15

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹448.00

Low₹425.10

Open at₹432.55

Prev Close₹430.80

Volumes4.54 L

Avg Price₹439.51

Lower Circuit₹344.65

Upper Circuit₹516.95

Historical Performance

3M High₹514.90

3M Low₹300.40

1 Yr High₹1,121.15

1 Yr Low₹266.70

3 Yr High₹1,360.00

3 Yr Low₹266.70

5 Yr High₹1,360.00

5 Yr Low₹266.70

Summary

As of 09-07-2026 17:17, Cohance Lifesciences Ltd. share price today is ₹0, with a change of ₹-430.80 (-100.00%) from the previous close of ₹430.8. The stock opened at ₹432.55 and traded between ₹425.1 and ₹448, with a total traded volume of 454022 shares. The company has a market capitalization of ₹16922.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1121.15 and ₹266.7, respectively.

Cohance Lifesciences Ltd. valuation metrics include a P/E ratio of 94.4, EPS of ₹4.69, and book value of ₹4.30. Profitability indicators show ROE of 4.58%. Cohance Lifesciences Ltd. has reported revenue of ₹2268.55 Cr and net profit of ₹179.23 Cr.

Cohance Lifesciences Ltd. technical indicators include Day RSI at 51.97, Day MFI at 86.39, Day ADX at 39.07. Additional indicators include Commodity Channel Index (CCI) at 22.5 and Williams %R at -53.02. Momentum indicators show Day MACD at 6.97, Day MACD Signal Line at 6.28, DayATR at 18.87. Rate of Change indicators for Cohance Lifesciences Ltd. include ROC125 at -16.32 and ROC21 at 2.61.

Exponential moving averages include EMA5 at ₹449.1, EMA10 at ₹447.2, EMA12 at ₹446, EMA20 at ₹441.9, EMA26 at ₹439, EMA50 at ₹427.7, EMA100 at ₹435.8, EMA200 at ₹527. Simple moving averages include SMA5 at ₹450.7, SMA10 at ₹453.8, SMA20 at ₹438, SMA30 at ₹435.1, SMA50 at ₹441.5, SMA100 at ₹380.4, SMA150 at ₹414.5, SMA200 at ₹513.

Support levels for Cohance Lifesciences are placed at First Support ₹432.23, Second Support ₹422.12, Third Support ₹410.23. Resistance levels are seen at First Resistance ₹454.23, Second Resistance ₹466.12, Third Resistance ₹476.23. Cohance Lifesciences Ltd. shareholding pattern shows promoter holding at 57.49%, FII holding at 5.59%, DII holding at 0%, public holding at 15.11%.

Cohance Lifesciences Fundamentals

Market Cap

High in industry

16,922.90 Cr.

PE Ratio (TTM)

High in industry

94.40

Dividend Yield

Net Profit TTM

33% decr over last year

179.23

Net Profit Growth

33% decr over last year

179.23

PEG Ratio

Negative PEG TTM

-2.90

ROE

71% decr over last year

4.58

Operating Revenue TTM

2,268.55

Operating Revenue Growth

89.4% incr over last year

Book Value

Above industry Median

4.30

MFI

MFI strongly Overbought

86.39

RSI

RSI is mid-range

51.97

EPS (TTM)

4.69

Debt to Equity

0.04

Face Value

Operating Profit Margin Qtr.

18.54

Operating Profit Qtr.

98.68

Net Profit Qtr.

19.55

Operating Revenue Qtr.

619.12

PB Ratio

4.30

Cohance Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	567.55	481.58	497.79	483.58	330.17
Operating Expense	450.98	378.80	366.93	379.38	262.99
Operating Profit	116.57	102.78	130.86	104.20	67.18
Depreciation	37.66	33.36	31.20	31.36	15.19
Interest	5.17	5.25	5.24	6.80	2.30
Tax	21.88	18.14	26.43	18.47	11.98
Net Profit	34.56	47.29	94.29	52.57	44.34

Cohance Lifesciences Technicals

Cohance Lifesciences Ltd. EMA & SMA

₹441.00

-11.95 (-2.64%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹449.1

Day EMA10 ₹447.2

Day EMA12 ₹446

Day EMA20 ₹441.9

Day EMA26 ₹439

Day EMA50 ₹427.7

Day EMA100 ₹435.8

Day EMA200 ₹527

Cohance Lifesciences Support and Resistance

Resistance

First Resistance₹454.23

Second Resistance₹466.12

Third Resistance₹476.23

Support

First Support₹432.23

Second Support₹422.12

Third Support₹410.23

Technical Indicators

Day RSI51.97

Day MFI86.39

Day ADX39.07

Day Commodity Channel Index22.50

William-53.02

Day MACD6.97

Day MACD Signal Line6.28

Day ATR18.87

Day ROC125-16.32

Day ROC212.61

Cohance Lifesciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	50.1	50.1	66.4	57.5	57.5	57.5
FII	10.8	11	7.2	6.5	6	5.6
DII	16.7	16.7	11.4	20.8	21.6	21.8
Public	22.4	22.2	15	15.2	14.9	15.1

Cohance Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.26 L	4.79 L	47.25%
Week	1.84 L	4.13 L	44.45%
1 Month	5.22 L	21.8 L	23.94%
6 Month	7.28 L	29.72 L	24.48%

Cohance Lifesciences SWOT Analysis

Strengths8

Weakness12

Opportunity2

Threats0

Benjamin Graham Value Screen

Expensive Performers (DVM)

PEG lower than Industry PEG

Overbought by Money Flow Index (MFI)

Companies with Low Debt

Companies with Zero Promoter Pledge

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Cohance Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
09 Sep, 2022	1	INTERIM	12 Sep, 2022	Equity Share
09 Sep, 2022	5	SPECIAL	12 Sep, 2022	Equity Share
13 May, 2022	1	INTERIM	17 May, 2022	Equity Share
13 May, 2022	1	SPECIAL	17 May, 2022	Equity Share
15 Feb, 2022	1	INTERIM	16 Feb, 2022	Equity Share
15 Feb, 2022	2	SPECIAL	16 Feb, 2022	Equity Share
13 Aug, 2021	1	FINAL	17 Aug, 2021	Equity Share
17 Feb, 2021	1	INTERIM	18 Feb, 2021	Equity Share

Cohance Lifesciences Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,027.20	₹807	₹1,418.10	₹1,625	₹4,508	₹660
% Change	2.41%	0.84%	0.59%	0.81%	-0.69%	1.95%
Revenue TTM (₹ Cr)	₹1,403.18	₹642.26	₹649.50	₹1,421.59	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	₹172.89	₹115.38	₹-73.80	₹257.90	₹255.19
PE TTM	65.70	53.00	54.20	-252.70	41.10	40.10
1 Year Return	87.27	36.75	136.79	-18.59	-14.34	14.03
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 992.00

+0.93%

BLUEJET

Blue Jet Healthcare Ltd

₹ 575.75

+2.32%

CONCORDBIO

Concord Biotech Ltd.

₹ 1311.20

+4.08%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 704.00

+2.59%

SUPRIYA

Supriya Lifescience Ltd.

₹ 876.50

+1.72%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1145.90

+1.40%

ERIS

Eris Lifesciences Ltd.

₹ 1430.00

+0.99%

SYNGENE

Syngene International Ltd.

₹ 415.85

+1.03%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 816.00

+0.58%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 278.05

+2.99%

STAR

Strides Pharma Science Ltd.

₹ 1072.00

-0.81%

FDC

FDC Ltd.

₹ 431.70

+1.96%

SHILPAMED

Shilpa Medicare Ltd.

₹ 624.80

+4.95%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 972.00

+0.13%

NATCOPHARM

Natco Pharma Ltd.

₹ 961.55

-0.49%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2626.00

+3.86%

MARKSANS

Marksans Pharma Ltd.

₹ 278.80

+5.83%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1050.00

+4.76%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 526.90

+2.72%

SANOFI

Sanofi India Ltd.

₹ 3349.00

-0.96%

PGHL

Procter & Gamble Health Ltd.

₹ 6600.00

+5.39%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 590.00

+4.71%

FAQ's on COHANCE

What is the current share price of Cohance Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Cohance Lifesciences Ltd. is ₹ 441 on the NSE and ₹ 440.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Cohance Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Cohance Lifesciences Ltd. is approximately ₹ 16922.9 Cr.

What are the PE and PB ratios for Cohance Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Cohance Lifesciences Ltd. is 94.4, and the Price-to-Book (PB) ratio is 4.3.

What is the 52-Week High and Low for Cohance Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Cohance Lifesciences Ltd. shares was ₹ 1121.15, and the lowest price was ₹ 266.7.

Who are the major shareholders of Cohance Lifesciences Ltd.?

Significant shareholdings in Cohance Lifesciences Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Cohance Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Cohance Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Cohance Lifesciences Ltd.?

Cohance Lifesciences Ltd. last declared a INTERIM dividend of ₹ 1 per share for the financial period ending 2022. The record date was set as 2022-09-09, and the payment was/is scheduled around 2022-09-09. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy